Who owns Relmada Therapeutics Inc?
- Ticker: RLMD
- CUSIP Number: 75955j402
Tip: Access positions for across all investors
Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Relmada Therapeutics stock
Who bought or sold Relmada Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 1.3M | $4.4M | 29% | Sep 2024 |
|
| Vanguard Group | 1.3M | $3.8M | 0% | Jun 2024 |
|
| Deep Track Capital | 1.2M | $3.7M | 0% | Jun 2024 |
|
| Acadian Asset Management | 1.2M | $3.8M | -1% | Sep 2024 |
|
| Parsons Capital Management | 1.0M | $3.2M | 3% | Sep 2024 |
|
| Palo Alto Investors | 732k | $2.4M | 0% | Sep 2024 |
|
| BlackRock | 573k | $1.7M | -1% | Jun 2024 |
|
| BlackRock | 568k | $1.8M | 100% | Sep 2024 |
|
| Vestal Point Capital | 490k | $1.6M | -59% | Sep 2024 |
|
| Opaleye Management | 480k | $1.6M | -20% | Sep 2024 |
|
| Jpmorgan Chase & Co | 315k | $1.0M | -11% | Sep 2024 |
|
| Geode Capital Management | 305k | $987k | 17% | Sep 2024 |
|
| Two Sigma Advisers | 293k | $878k | -10% | Jun 2024 |
|
| Deutsche Bank Aktiengesellschaft | 225k | $729k | 0% | Sep 2024 |
|
| Bank of America Corporation | 207k | $670k | -1% | Sep 2024 |
|
| Two Sigma Investments | 203k | $610k | -10% | Jun 2024 |
|
| Susquehanna International | 181k | $587k | 84% | Sep 2024 |
|
| Bridgeway Capital Management | 181k | $543k | -8% | Jun 2024 |
|
| Citadel Advisors | 171k | $553k | 10% | Sep 2024 |
|
| Jacobs Levy Equity Management | 158k | $511k | 100% | Sep 2024 |
|
| Barclays | 146k | $473k | 0% | Sep 2024 |
|
| GSA Capital Partners | 108k | $351k | 0% | Sep 2024 |
|
| State Street Corporation | 106k | $318k | -5% | Jun 2024 |
|
| We Are One Seven | 100k | $324k | 0% | Sep 2024 |
|
| Silverarc Capital Management | 99k | $298k | 0% | Jun 2024 |
|
| Group One Trading | 99k | $321k | -34% | Sep 2024 |
|
| AdvisorShares Investments | 90k | $276k | 29% | Jun 2024 |
|
| Federated Investors | 87k | $283k | -9% | Sep 2024 |
|
| apricus wealth | 79k | $256k | 0% | Sep 2024 |
|
| Northern Trust | 75k | $242k | -8% | Sep 2024 |
|
| Dimensional Fund Advisors | 73k | $238k | 0% | Sep 2024 |
|
| ExodusPoint Capital Management | 68k | $220k | 100% | Sep 2024 |
|
| Citigroup | 63k | $204k | 0% | Sep 2024 |
|
| Tang Capital Management | 51k | $165k | -79% | Sep 2024 |
|
| Marshall Wace | 51k | $164k | -68% | Sep 2024 |
|
| Morgan Stanley | 46k | $139k | -62% | Jun 2024 |
|
| Ikarian Capital | 40k | $131k | 0% | Sep 2024 |
|
| Sei Investments | 36k | $117k | 0% | Sep 2024 |
|
| Squarepoint Ops | 35k | $106k | -55% | Jun 2024 |
|
| AlTi Global | 32k | $104k | 0% | Sep 2024 |
|
| American Century Companies | 32k | $102k | 0% | Sep 2024 |
|
| Pensionmark Financial Group | 31k | $92k | 0% | Jun 2024 |
|
| Horizon Kinetics Asset Management | 30k | $90k | 0% | Jun 2024 |
|
| Pegasus Asset Management | 27k | $87k | 0% | Sep 2024 |
|
| Renaissance Technologies | 26k | $84k | -71% | Sep 2024 |
|
| Tortoise Investment Management | 22k | $70k | 0% | Sep 2024 |
|
| Sargent Investment Group | 22k | $70k | 0% | Sep 2024 |
|
| Wolverine Trading | 21k | $71k | 69% | Sep 2024 |
|
| Rothschild Investment | 20k | $65k | 100% | Sep 2024 |
|
| Spotlight Asset Group | 20k | $60k | 0% | Jun 2024 |
|
| LPL Financial | 14k | $44k | -13% | Sep 2024 |
|
| Belvedere Trading | 13k | $43k | -52% | Sep 2024 |
|
| Simplex Trading | 13k | $40k | -70% | Sep 2024 |
|
| Charles Schwab Investment Management | 13k | $41k | 0% | Sep 2024 |
|
| Mariner Wealth Advisors | 12k | $40k | -29% | Sep 2024 |
|
| Beacon Pointe Advisors | 10k | $33k | 0% | Sep 2024 |
|
| Bedel Financial Consulting | 10k | $32k | 0% | Sep 2024 |
|
| Hexagon Capital Partners | 4.0k | $13k | 0% | Sep 2024 |
|
| Brown Brothers Harriman & Co. | 3.0k | $9.0k | 0% | Jun 2024 |
|
| Tower Research Capital | 2.8k | $8.3k | -72% | Jun 2024 |
|
| Lindbrook Capital | 2.5k | $8.1k | 0% | Sep 2024 |
|
| American Capital Advisory | 2.0k | $6.3k | 63% | Sep 2024 |
|
| Royal Bank of Canada | 1.5k | $5.0k | -48% | Sep 2024 |
|
| Wells Fargo & Company | 350.00 | $1.1k | 0% | Sep 2024 |
|
| Fortitude Family Office | 252.00 | $816.001200 | 0% | Sep 2024 |
|
| Golden State Equity Partners | 200.00 | $648.000000 | 100% | Sep 2024 |
|
| Massmutual Trust | 113.00 | $365.995700 | 0% | Sep 2024 |
|
| Larson Financial Group | 100.00 | $324.000000 | 100% | Sep 2024 |
|
| Qube Research & Technologies | 56.00 | $168.000000 | -100% | Jun 2024 |
|
| Russell Investments | 53.00 | $159.000000 | 100% | Jun 2024 |
|
| Advisor Group Holdings | 27.00 | $86.999400 | 0% | Sep 2024 |
|
| Front Row Advisors | 6.00 | $19.000200 | 0% | Sep 2024 |
|
Who sold out of Relmada Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Mar 2024 | 118k | $550k |
| Guild Investment Management | Jun 2024 | 74k | $221k |
| Millennium Management | Jun 2024 | 64k | $193k |
| Jane Street | Jun 2024 | 38k | $112k |
| Balyasny Asset Management | Mar 2024 | 12k | $57k |
| Cantor Fitzgerald, L. P. | Jun 2024 | 10k | $30k |
| Rhumbline Advisers | Jun 2024 | 1.1k | $3.4k |
| Macquarie Group | Mar 2024 | 856.00 | $4.023200 |
| GAMMA Investing | Jun 2024 | 228.00 | $684.000000 |
| Smartleaf Asset Management | Jun 2024 | 35.00 | $103.999000 |